Pyridostigmine BR 30 MG tablet UU 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FSXZ7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,045
Award facts
- Contract value 100% obligated
- $2,045.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,045.35 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 30 mg tablets. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 14, 2026. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly doing business as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems. Pyridostigmine bromide is an acetylcholinesterase inhibitor commonly used in the treatment of myasthenia gravis and other neuromuscular disorders, representing one of many specialized pharmaceutical products the contractor supplies through its federal contract portfolio. The competitively awarded status and firm fixed-price structure demonstrate AmerisourceBergen's ability to meet federal procurement standards for essential pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FSXZ7?
SPE2DR26FSXZ7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FSXZ7 worth?
The government has obligated $2,045 on SPE2DR26FSXZ7.
Is contract SPE2DR26FSXZ7 an order under another contract?
Yes. SPE2DR26FSXZ7 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSXZ7 competed?
The extent of competition for SPE2DR26FSXZ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award